Get started
NERVGEN PHARMA CORPNERVGEN PHARMA CORPNERVGEN PHARMA CORP

NERVGEN PHARMA CORP

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

NGEN chart

Key stats

Market capitalization
‪117.82 M‬CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.38CAD
Net income
‪−22.38 M‬CAD
Revenue
—
Shares float
‪43.24 M‬
Beta (1Y)
−0.02

About NERVGEN PHARMA CORP

Sector
Health Technology
CEO
Michael Kelly
Headquarters
Vancouver
Website
nervgen.com
Founded
2017
ISIN
CA64082X2032
FIGI
BBG00MMMWFG2
NervGen Pharma Corp. operates as a clinical stage biotech company. It provides development of treatment that enables the nervous system to repair itself following damage, whether due to injury or disease. The company was founded by Harold Punnett and William Joseph Radvak on January 19, 2017 and is headquartered in Vancouver, Canada.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NGEN is 2.12 CAD — it has increased by 6.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange NERVGEN PHARMA CORP stocks are traded under the ticker NGEN.
NERVGEN PHARMA CORP is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
NGEN stock is 7.58% volatile and has beta coefficient of −0.02. Check out the list of the most volatile stocks — is NERVGEN PHARMA CORP there?
One year price forecast for NERVGEN PHARMA CORP has a max estimate of 5.00 CAD and a min estimate of 5.00 CAD.
NGEN earnings for the last quarter are −0.06 CAD per share, whereas the estimation was −0.14 CAD resulting in a 57.14% surprise. The estimated earnings for the next quarter are −0.12 CAD per share. See more details about NERVGEN PHARMA CORP earnings.
Yes, you can track NERVGEN PHARMA CORP financials in yearly and quarterly reports right on TradingView.
NGEN stock has fallen by 1.40% compared to the previous week, the month change is a 14.17% fall, over the last year NERVGEN PHARMA CORP has showed a 31.68% increase.
NGEN net income for the last quarter is ‪−8.61 M‬ CAD, while the quarter before that showed ‪−4.30 M‬ CAD of net income which accounts for −100.08% change. Track more NERVGEN PHARMA CORP financial stats to get the full picture.
Today NERVGEN PHARMA CORP has the market capitalization of ‪119.01 M‬, it has decreased by 4.42% over the last week.
No, NGEN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NERVGEN PHARMA CORP stock right from TradingView charts — choose your broker and connect to your account.
NGEN reached its all-time high on Feb 5, 2024 with the price of 3.98 CAD, and its all-time low was 0.80 CAD and was reached on Mar 25, 2020.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NERVGEN PHARMA CORP technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NERVGEN PHARMA CORP stock shows the neutral signal. See more of NERVGEN PHARMA CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NERVGEN PHARMA CORP future price: according to them, NGEN price has a max estimate of 5.00 CAD and a min estimate of 5.00 CAD. Read a more detailed NERVGEN PHARMA CORP forecast: see what analysts think of NERVGEN PHARMA CORP and suggest that you do with its stocks.